Diatreme Resources (ASX:DRX) Awarded Major Project Status for Northern Silica Project
Diatreme Resources (ASX:DRX) secures Major Project Status for Northern Silica Project, enhancing support and regional growth.
Diatreme Resources (ASX:DRX) secures Major Project Status for Northern Silica Project, enhancing support and regional growth.
Dubber Corporation Limited (ASX:DUB) initiates recovery actions after discovering $26.6m in misappropriated company funds.
Lunnon Metals (ASX:LM8) completes a robust scoping study for its Lady Herial gold deposit, highlighting strong financial outcomes and strategic negotiations.
Challenger Limited (ASX:CGF) supports APRA’s new capital settings for annuities, enhancing Australia’s retirement income market.
PYC Therapeutics (ASX:PYC) receives approval to escalate dosing in its ADOA clinical trial, advancing development of its PYC-001 drug candidate.
Radiopharm Theranostics (ASX:RAD) secures FDA Fast Track for RAD101, advancing its Phase 2 trial in brain metastases imaging.
Centrex Limited (ASX:CXM) reconvenes its second creditors meeting, proposing a DOCA by PRL Global Limited.
Syntara Limited (ASX:SNT) secures FDA Fast Track for its myelofibrosis treatment SNT-5505, accelerating its development towards becoming a new standard of care.
Cazaly Resources (ASX:CAZ) secures approval to begin drilling at Goongarrie Gold Project, advancing its exploration efforts.
Lithium Plus Minerals (ASX:LPM) retracts previous pricing information and announces new beryllium mineral discoveries at Arunta Projects.